Faculty Disclosures
| Alexis Davis, MS |
Ms. Davis has nothing to disclose. |
| Santosh Pandey, MVSc, DABT |
Mr. Pandey has nothing to disclose. |
| Cynthia Gibson, NP |
Ms. Gibson has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylx. |
| Michael McLinden |
No disclosure on file
|
| Emma Ciafaloni, MD, FAAN |
Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care. |
| Abidemi Otaiku, MD |
Dr. Otaiku has nothing to disclose. |
| Renny Abraham, PhD |
Mr. Abraham has nothing to disclose. |
| Vijay Benade |
Vijay Benade has nothing to disclose. |
| Brandon Diessner, PhD |
Dr. Diessner has received personal compensation for serving as an employee of Optum. Dr. Diessner has stock in UnitedHealth Group. |
| Ramakrishna Nirogi, PhD |
Dr. Nirogi has nothing to disclose. |
| Satish Jetta |
Satish Jetta has received intellectual property interests from a discovery or technology relating to health care. |
| Pablo R. Castillo, MD, FAAN |
Dr. Castillo has nothing to disclose. |
| Amy Anderson |
Ms. Anderson has received personal compensation for serving as an employee of AstraZeneca. Ms. Anderson has received personal compensation for serving as an employee of Optum. Ms. Anderson has stock in UnitedHealth Group. |
| Veera Raghava Chowdary Palacharla, Scientist |
Mr. Palacharla has stock in Suven Life Sciences Limited. Mr. Palacharla has received intellectual property interests from a discovery or technology relating to health care. |
| Meaghan Berns, MD |
Dr. Berns has nothing to disclose. |
| Dana Y. Teltsch, PhD |
Dr. Teltsch has received personal compensation for serving as an employee of Takeda. Dr. Teltsch has stock in Takeda. |
| Luqman Munir |
Mr. Munir has nothing to disclose. |
| Amelie Lothe, PhD |
Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has or had stock in UCB. |
| CHRIS CLARK |
Mr. CLARK has received personal compensation for serving as an employee of UCB. |
| Scott McIntosh, PhD |
Dr. McIntosh has nothing to disclose. |
| John van Zyl |
Mr. van Zyl has received personal compensation for serving as an employee of UCB. |
| Bonnie K. Bui, PhD |
Dr. Bui has received personal compensation for serving as an employee of Optum. Dr. Bui has stock in UNH. |
| Venkat Jasti |
Venkat Jasti has stock in Suven Life Sciences Ltd. Venkat Jasti has received intellectual property interests from a discovery or technology relating to health care. |
| Jennifer L. Marsella, MD |
Dr. Marsella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed, EBSCO Information Services. Dr. Marsella has received personal compensation in the range of $500-$4,999 for serving as a Content Contributor with the American Academy of Neurology. |
| Jyothsna Ravula |
No disclosure on file
|
| Reza Y. Yousefi Nooraie, PhD |
Dr. Yousefi Nooraie has nothing to disclose. |
| Phani Veeranki, MD, DrPH |
Dr. Veeranki has received personal compensation for serving as an employee of Optum . Dr. Veeranki has stock in Optum. |
| Erjia Cui |
Dr. Cui has nothing to disclose. |
| Stephen Joza, MD, PhD |
Dr. Joza has nothing to disclose. |
| Mohammad Ammar Ur Rahman, MBBS |
Dr. Ammar Ur Rahman has nothing to disclose. |
| Michael J. Howell, MD, FAAN |
The institution of Dr. Howell has received research support from National Institutes of Health. Dr. Howell has received publishing royalties from a publication relating to health care. |
| Amy Duhig, PhD |
Dr. Duhig has received personal compensation for serving as an employee of Takeda . Dr. Duhig has stock in Takeda. |
| Anil Shinde |
Anil Shinde has received intellectual property interests from a discovery or technology relating to health care. |
| Sara Sohail |
Sara Sohail has nothing to disclose. |
| Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc |
Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techspert. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and Education in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . The institution of Dr. Boulos has received research support from Zoll Itamar. The institution of Dr. Boulos has received research support from Toronto Dementia Research Alliance. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lundbeck. |
| Vinod Goyal |
Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care. |
| DANIEL S. LLOYD |
Mr. LLOYD has received personal compensation for serving as an employee of UCB. |
| Pradeep Jayarajan, PhD |
Pradeep Jayarajan, PhD has received personal compensation for serving as an employee of Suven Life Sciences Ltd. Pradeep Jayarajan, PhD has or had stock in Suven Life Sciences.Pradeep Jayarajan, PhD has received intellectual property interests from a discovery or technology relating to health care. |
| Azka Ijaz, MBBS |
Miss Ijaz has nothing to disclose. |
| Stefanie Dedeurwaerdere, PhD |
Mrs. Dedeurwaerdere has received personal compensation for serving as an employee of UCB Pharma. Mrs. Dedeurwaerdere has stock in UCB Pharma. Mrs. Dedeurwaerdere has received intellectual property interests from a discovery or technology relating to health care. |
| Yelena G. Pyatkevich |
No disclosure on file
|
| Ramkumar S, Chief Scientist |
Mr. S has nothing to disclose. |
| Neha V. Reddy, MD |
Dr. Reddy has nothing to disclose. |
| Stephen Crawford, PhD |
Dr. Crawford has received personal compensation for serving as an employee of Takeda. Dr. Crawford has stock in Takeda. |
| Anne M. Morse, DO |
Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alkermes. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Harmony biosciences. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Hayes solicitors. Dr. Morse has received publishing royalties from a publication relating to health care. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with DAMM Good Sleep, LLC. |
| Abdul Rasheed Mohammed, PhD |
Mr. Mohammed has nothing to disclose. |